Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate Cancer, Castration Resistant”

1,138 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,138 results

Testing effectiveness (Phase 2)Study completedNCT00887458
What this trial is testing

A Two-dose Level Clinical Trial of Itraconazole in Patients With Metastatic Prostate Cancer Who Have Had Disease Progression While on Hormonal Therapy

Who this might be right for
Prostate Cancer
Johns Hopkins University 46
Not applicableUnknownNCT01590498
What this trial is testing

Radiotherapy vs Observation for CRPC

Who this might be right for
Hormone Refractory Prostate Cancer
Zhengzhou University 2,000
Testing effectiveness (Phase 2)Looking for participantsNCT06567314
What this trial is testing

Phase 2 Study of Ivonescimab in Patients With Cutaneous Squamous Cell Carcinoma

Who this might be right for
Cutaneous Squamous Cell Carcinoma
M.D. Anderson Cancer Center 24
Early research (Phase 1)Ended earlyNCT04249947
What this trial is testing

P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC)

Who this might be right for
Prostatic Neoplasms, Castration-ResistantNeoplasms by Histologic TypeNeoplasms, Prostate+14 more
Poseida Therapeutics, Inc. 40
Post-approval studies (Phase 4)Study completedNCT02405858
What this trial is testing

Abiraterone Acetate in Metastatic Castration-Resistant Prostate Cancer Participants Who Responded Poorly to the First-line Combined Androgen Blockade Therapy

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
Janssen Pharmaceutical K.K. 51
Testing effectiveness (Phase 2)Study completedNCT02344017
What this trial is testing

Safety and Pharmacokinetics of ODM-204 in Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Orion Corporation, Orion Pharma 23
Early research (Phase 1)Study completedNCT02202447
What this trial is testing

Phase 1 of EC1169 In Patients With Recurrent MCRPC

Who this might be right for
Prostate Cancer
Endocyte 40
Testing effectiveness (Phase 2)UnknownNCT02525068
What this trial is testing

Enzalutamide in Combination With AZD5363 in Patients With mCRPC

Who this might be right for
Adenocarcinoma of the Prostate
Institute of Cancer Research, United Kingdom 136
Not applicableStudy completedNCT06461689
What this trial is testing

Comparison of Changes in Tumor Burden in 68Ga-PSMA-11 PET/CT and 177Lu-PSMA SPECT/CT in Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Prostate Cancer Metastatic
Central Hospital, Nancy, France 80
Large-scale testing (Phase 3)Looking for participantsNCT07213674
What this trial is testing

Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Amgen 750
Early research (Phase 1)Active Not RecruitingNCT04898634
What this trial is testing

JNJ-78278343, a T-Cell-Redirecting Agent Targeting Human Kallikrein 2 (KLK2), for Advanced Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Janssen Research & Development, LLC 216
Testing effectiveness (Phase 2)Looking for participantsNCT07259213
What this trial is testing

Terbium 161 (161Tb)-RAD402 in Participants With CRPC

Who this might be right for
Castration-resistant Prostate Cancer
Radiopharm Theranostics, Ltd 73
Early research (Phase 1)WithdrawnNCT02396368
What this trial is testing

Radium-223 in Combination With Tasquinimod in Bone-only Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostate CancerBone-only Metastatic Castration-Resistant Prostate Cancer (CRPC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)Looking for participantsNCT07287150
What this trial is testing

Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
Hoffmann-La Roche 100
Early research (Phase 1)Active Not RecruitingNCT06193993
What this trial is testing

Effect of Low-dose 500 mg Abiraterone Acetate in Treatment of Metastatic Prostate Cancer Patients

Who this might be right for
Prostate CancerMetastatic CancerHormone Sensitive Prostate Cancer+1 more
National University Hospital, Singapore 10
Early research (Phase 1)Study completedNCT01949519
What this trial is testing

Docetaxel and Lycopene in Metastatic Prostate Cancer

Who this might be right for
Adenocarcinoma of the Prostate
Medical University of South Carolina 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT03787680
What this trial is testing

Targeting Resistant Prostate Cancer With ATR and PARP Inhibition (TRAP Trial)

Who this might be right for
Prostate Cancer
University of Michigan Rogel Cancer Center 49
Testing effectiveness (Phase 2)Study completedNCT01795703
What this trial is testing

Evaluate Safety and Efficacy of Abiraterone in Participants With Prostate Cancer Who Have Received Docetaxel

Who this might be right for
Prostate Cancer
Janssen Research & Development, LLC 47
Early research (Phase 1)Looking for participantsNCT07514065
What this trial is testing

TSL2109 Capsules in Advanced Solid Tumor Patients: Safety, Tolerability, PK and Preliminary Efficacy

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer Patients
Tasly Pharmaceutical Group Co., Ltd 78
Early research (Phase 1)Not Yet RecruitingNCT06866795
What this trial is testing

Phase 1 Clinical Study of GT-220F in Subjects With Metastatic Castration Resistant Prostate Cancer (mCRPC)

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Geode Therapeutics Inc. 42
Next Page